Revitalizing Japan's biomedical ecosystem: Policy initiatives, challenges, and future directions

Okuyama R

Drug Discov Ther. 2025; 19(4):214-219.

DOI: 10.5582/ddt.2025.01056

Summary Full Text (PDF)

Serum lipid levels serve as predictors for osteoporosis or osteopenia in postmenopausal women: A meta-analysis of observational studies

Ye FJ, Zhang YL, Chen ZQ, Zhou J, Wang J, Fu XY, Qi Q, Wang L

Drug Discov Ther. 2025; 19(4):220-229.

DOI: 10.5582/ddt.2025.01067

Summary Full Text (PDF)

Bovine lactoferrin intake prevents hepatic injury in a mouse model of non-alcoholic steatohepatitis induced by choline and methionine deficiency

Aoki R, Ishido K, Furukawa M, Ishibashi Y, Nozaki S, Ito N, Toho M, Nagashima D, Izumo N

Drug Discov Ther. 2025; 19(4):230-236.

DOI: 10.5582/ddt.2025.01047

Summary Full Text (PDF)

Piezo1 mediates calcium ion influx, glucose transporter 4 translocation, and glucose uptake in adipocytes under low-frequency vibration

Huang DZ, Haba D, Tomida S, Takizawa C, Qin Q, Kataoka Y, Mugita Y, Sanada H, Nakagami G

Drug Discov Ther. 2025; 19(4):237-244.

DOI: 10.5582/ddt.2025.01061

Summary Full Text (PDF)

Evaluation of electrospun composite biomaterial and porcine small intestine submucosa patch in open inguinal herniorrhaphy: A prospective, randomized, single-blind, controlled, multicenter, 72-month clinical study

Qiu ZY, Fang L, Li SJ, Tang JX, Pang Y, Wang J, Zhou J, Wang L, Chen L

Drug Discov Ther. 2025; 19(4):245-252.

DOI: 10.5582/ddt.2025.01066

Summary Full Text (PDF)

Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): An interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments

Shimizu T, Kawashiri SY, Koga T, Kiya R, Morita M, Kuroda S, Tashiro S, Sato S, Yano H, Asano T, Saito K, Yoshitama T, Ueki Y, Eiraku N, Yamada Y, Okano T, Ushio Y, Dobashi H, Itami T, Tomita D, Nozaki Y, Hosogaya N, Yamamoto H, Kawakami A

Drug Discov Ther. 2025; 19(4):253-261.

DOI: 10.5582/ddt.2025.01044

Summary Full Text (PDF)

Anti-Mycobacterium avium complex activities of streptcytosine analogs from a marine actinomycete as nucleoside antibiotics

Oshima N, Yagi A, Yamazaki H, Uchida R

Drug Discov Ther. 2025; 19(4):262-266.

DOI: 10.5582/ddt.2025.01052

Summary Full Text (PDF)

Implementation and evaluation of a structured lecture-based training program for early-career pharmacists

Nonomiya Y, Nakamura M, Nakamura T, Yamaguchi M

Drug Discov Ther. 2025; 19(4):267-270.

DOI: 10.5582/ddt.2025.01063

Summary Full Text (PDF)

A pilot study investigating the efficiency of an Internet of things (IOT)-aided warehouse management system in the management of consumables for the operating room in a Chinese setting

Zhang GM, Wang Q, Zhao L, Zhang H, Lin J, Asakawa T

Drug Discov Ther. 2025; 19(4):271-274.

DOI: 10.5582/ddt.2025.01068

Summary Full Text (PDF)

Telisotuzumab vedotin: The first-in-class c-Met-targeted antibody-drug conjugate granted FDA accelerated approval for treatment of non-squamous non-small cell lung cancer (NSCLC)

Zhao CR, Lu DR, Gao JJ

Drug Discov Ther. 2025; 19(4):275-276.

DOI: 10.5582/ddt.2025.01058

Summary Full Text (PDF)